This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: H. Lundbeck A/s. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Brian Baker: Innovator in Glucose Metabolism Regulation
Introduction
Brian Baker is a notable inventor based in Kirkland, WA (US). He has made significant contributions to the field of metabolic disorders through his innovative research and patent.
Latest Patents
Brian Baker holds a patent for the regulation of glucose metabolism using anti-CGRP antibodies. This patent provides methods for the prevention or treatment of metabolic disorders. The disclosed methods involve administering an anti-CGRP antibody, optionally in combination with a second agent, to increase peripheral and/or hepatic glucose utilization. This approach aims to prevent or treat diseases and disorders associated with insulin resistance. The compositions comprising the anti-CGRP antibody are designed for effective administration to enhance glucose utilization.
Career Highlights
Brian Baker is associated with H. Lundbeck A/S, where he applies his expertise in metabolic research. His work focuses on developing innovative solutions to combat insulin resistance and related metabolic disorders.
Collaborations
Some of his coworkers include Jeffrey Tl Smith and John A Latham, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Brian Baker's contributions to glucose metabolism regulation highlight his role as an innovator in the field of metabolic disorders. His patent reflects a significant advancement in the treatment of insulin resistance, showcasing the potential for improved health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile